%0 Journal Article %T Is Levodopa Pharmacokinetics in Patients with Parkinson¡¯s Disease Depending on Gastric Emptying? %A Maria Nord %A Anita Kullman %A Ulf Hannestad %A Nil Dizdar %J Advances in Parkinson's Disease %P 1-12 %@ 2169-9720 %D 2017 %I Scientific Research Publishing %R 10.4236/apd.2017.61001 %X Levodopa uptake from the gastrointestinal tract in patients with Parkinson¡¯s disease (PD) can be affected by delayed gastric emptying (GE). This might lead to fluctuating levodopa levels resulting in increased motor fluctuations. Continuous dopaminergic stimulation (CDS) improves motor fluctuations and could be a result of smoothening in levodopa uptake. In this study we wanted to study the levodopa pharmacokinetics peripherally in PD patients with motor fluctuations and investigate the relation between levodopa uptake and GE and the effect of CDS. PD patients with wearing off (group 1) and on-off syndrome (group 2) were included. Breath tests were performed to evaluate the half time (T1/2) of GE. Concomitantly 1 tablet of Madopark&reg; was given and the levodopa concentrations in blood and subcutaneous (SC) tissue were analyzed for both groups. Group 2 was then given a 10-d continuous intravenous levodopa treatment and the tests were repeated. Higher levels of levodopa in group 1 compared to group 2 in blood (p = 0.014) were seen. The GE was delayed in both group 1 (p < 0.001) and group 2 (p < 0.05) compared to a reference group with healthy volunteers with T1/2 median values 105 and 78 min vs. 72 min. There was no difference in GE between the two PD groups (p = 0.220) or in group 2 before and after infusion period (p = 0.861). CDS resulted in lower levodopa levels in blood (p < 0.001) and SC tissue (p < 0.01). In conclusion, PD patients in early complication phase have a more favourable levodopa uptake than patients later in disease. We found delayed GE in PD patients with motor fluctuations but no obvious relation between GE and levodopa uptake or GE and PD stage. The effect of CDS indicates no effect of CDS on the mechanisms of GE but on the mechanisms of levodopa uptake. %K Parkinson Disease %K Levodopa %K Gastric Emptying %K Continuous Dopaminergic Stimulation %K Microdialysis %U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=73934